Accelagen

Accelagen is a private, San Diego-based contract service provider focused on the gene-to-protein workflow for biopharmaceutical and research clients. Founded in 2010, the company offers a comprehensive suite of services including custom antibody development, recombinant protein production in E. coli, baculovirus, and mammalian systems, and protein purification. Its mission is to deliver cost-effective, high-quality protein services to accelerate drug discovery programs, supporting applications from high-throughput screening and structural biology to preclinical studies. Accelagen positions itself as a premium partner with a strong track record of timely project completion for a diverse range of challenging protein targets.

Integrated multi-system gene-to-protein platform utilizing Baculovirus (BEVS), mammalian, and E. coli expression systems, coupled with Wave bioreactors, Cell Factory, and AKTA chromatography for protein production and purification.

Accelagen competes in a fragmented but crowded market. Competitors range from large, full-service CROs (e.g., Lonza, Thermo Fisher Scientific) to specialized protein production boutiques and academic core facilities. Differentiation is based on technical expertise in difficult targets, quality of service, turnaround time, and cost. The company positions itself as a premium, high-touch provider for complex projects.